摘要
阿拉伯糖-5-磷酸异构酶(Kds D)是2-酮-3-脱氧辛糖酸(KDO)生物合成途径的第一个关键限速酶,通过无缝克隆技术将拟南芥Kds D基因构建至原核表达载体p ET-HTT,经过IPTG诱导,在大肠杆菌BL21(DE3)中获得了大量重组蛋白的可溶性表达;表达产物经Ni-NTA亲和层析和分子筛层析(SEC)方法进行酶蛋白的分离纯化步骤,得到纯度85%以上的高纯度酶;分子筛层析结果发现纯化后的目的蛋白Kds D在溶液中主要以多聚体、二聚体和单体形式存在,这同微生物来源Kds D酶在溶液中以四聚体形式存在很大差异;进一步使用Western blotting和MALDI-TOF MASS技术对纯化的蛋白进行鉴定;测定了拟南芥Kds D酶学性质,证明该酶催化反应的最适p H值为8.0,最适作用温度为37℃,各种金属离子在低浓度均对酶活性存在不同程度的抑制作用,其中以Co^(2+)、Cd^(2+)对酶活性的抑制作用最强,而5 mmol/L金属螯合剂EDTA对酶有激活作用。此外,以阿拉伯糖-5-磷酸(A5P)为底物时,拟南芥Kds D酶动力学常数Vmax和Km值分别为0.18 mmol/(L·min)、0.16 mmol/L,比较发现该酶与底物的亲和性高于大肠杆菌Kds D。以上研究结果为Kds D蛋白结构与功能及其在新型抗生素研制领域中的工业化应用奠定了基础。
Arabinose-5-phosphate isomerase(Kds D) is the first key limiting enzyme in the biosynthesis of 3-deoxy-D-manno-octulosonate(KDO).Kds D gene was cloned into prokaryotic expression vector p ET-HTT by seamless DNA cloning method and the amount of soluble recombinant protein was expressed in a soluble form in E.coli BL21(DE3) after induction of Isopropyl β-D-1-thiogalactopyranoside(IPTG).The target protein was separated and purified by Ni-NTA affinity chromatography and size exclusion chromatography,and its purity was more than 85%.Size exclusion chromatography showed that Kds D protein existed in three forms:polymers,dimmers,and monomers in water solution,different from microbial Kds D enzyme with the four polymers in water solution.Further,the purified protein was identified through Western blotting and MALDI-TOF MASS technology.The results of activity assay showed that the optimum p H and temperature of At Kds D isomerase activities were 8.0 and 37 ℃,respectively.The enzyme was activated by metal protease inhibitor EDTA(5 mmol/L) and inhibited by some metal ions at lower concentration,especially with Co2+ and Cd2+ metal ion.Furthermore,when D-arabinose-5-phosphate(A5P) was used as substrate,Km and Vmax of At Kds D values were 0.16 mmol/L,0.18 mmol/L·min.The affinity of At Kds D was higher than Kds D in E.coli combined with substrate.Above results have laid a foundation for the Kds D protein structure and function for its potential industrial application.
出处
《生物工程学报》
CAS
CSCD
北大核心
2016年第8期1060-1069,共10页
Chinese Journal of Biotechnology
基金
浙江省自然科学基金(No.Y14C160039)资助~~